As with many other medical conditions, treatment for alcohol use disorder (AUD) is not “one size fits all.” Different patients need different options. Fortunately, there are more AUD treatment choices than many people may expect. Evidence-based, quality treatment is offered at different levels of intensity and in a variety of settings to meet individual needs. Treatment can help patients achieve a goal of quitting drinking or of cutting down significantly, either of which can markedly improve their health status as well as how they feel and function. 1
Two types of evidence-based treatment for AUD are offered by healthcare professionals: behavioral healthcare and medications. They have been shown to be about equally effective 2 and can be combined and tailored to improve outcomes for each patient. Many patients also benefit from active participation in mutual support groups such as Alcoholics Anonymous (AA) or a number of secular alternatives (see Resources), either on their own or as a complement to professionally led treatment. 2
Support for patients with AUD is offered in more settings than just specialty addiction programs. Primary care professionals can offer medications for AUD along with brief counseling (see Core article on brief intervention). Addiction physicians, clinical psychologists, and other licensed therapists also provide outpatient care in solo or group practices (see Core article on referral). These and other flexible, convenient options such as telehealth professional services and online or in-person mutual support groups may reduce stigma and other barriers to recovery. Here, we briefly describe options available to help patients with AUD.
A note on a drinking level term used in this Core article: Heavy drinking has been defined for women as 4 or more drinks on any day or 8 or more per week, and for men as 5 or more drinks on any day or 15 or more per week.
Patients with less severe AUD may be able to receive treatment in primary care via brief interventions (see Core article on brief intervention) and FDA-approved AUD medications. For people with more severe AUD or with mental health comorbidities, it’s wise to seek evidence-based behavioral health treatment with a licensed professional therapist to set the stage for lasting change (see Core article on mental health issues).
Broadly, AUD-focused behavioral health treatment aims to help patients set goals, identify triggers that could prompt drinking, develop skills to stop or reduce drinking, manage emotions and stress, and build relationships that will support treatment goals. Specific evidence-backed approaches, which are about equally effective, 2 include the following:
Therapists who specialize in addiction can offer one-on-one, couples, family, or group sessions. These specialists can be found both in treatment programs and in solo or group practices. NIAAA’s Alcohol Treatment Navigator can guide you to providers who offer evidence-based behavioral health treatment near you, as well as telehealth and online options.
If you are a licensed therapist, see the Resources, below, for therapy manuals from NIAAA-sponsored clinical trials. The manuals contain modules for alcohol-focused CBT, motivational enhancement, mutual support group facilitation, and other evidence-based approaches that can help you treat clients who have AUD.
To date, three medications have been approved by the FDA to help prevent a return to heavy drinking. You don’t need specialized training or licensing to prescribe these non-addicting medications, so they are no more complicated to prescribe than those for other common medical conditions. As with treatment for other mental health conditions, such as depression, if a patient does not respond well to one medication, it is often worthwhile to try another.
These medications are vastly underused in treating AUD. They are prescribed for only 1.6% of adults with past-year AUD, according to a 2021 analysis. 8 Offering medications in primary care can be an effective “foot in the door” and can catalyze change for patients who may be reluctant to accept specialty treatment because of stigma or other barriers. 9 Your patients may be unaware of the newer medications (acamprosate and naltrexone) and may consider them more appealing than the older medication (disulfiram) that makes people feel sick if they drink alcohol. 10 You can also reassure patients that AUD medications are not addicting and are generally well tolerated. Therefore, people who take these medications can also participate in mutual support groups that advise members not to replace one drug of addiction with another.
If you are considering prescribing AUD medications, you can find support in several clinician’s guides (see Resources, below). 11–14 Some primary care physicians may be more comfortable prescribing AUD medications if they have prescribing support from addiction specialists or pharmacists as well as behavioral health support for follow-up. 9 If you would like to partner with a specialist prescriber or therapist, you can find them using the Navigator.
Mutual support groups may be beneficial for providing a sense of community for those in recovery. Groups vary widely in beliefs and demographics, so advise patients who are interested in joining a group to try different options to find a good fit. In addition to widely recognized 12-step programs with spiritual components such as AA, a number of secular groups promote abstinence as well, such as SMART Recovery, LifeRing, Women for Sobriety, Secular Organizations for Sobriety, and Secular AA (see Resources, below, for links).
Research suggests that three of the largest known secular groups in the U.S.—SMART Recovery, LifeRing, and Women for Sobriety—appear comparable in effectiveness to 12-step programs for people who have a goal of abstinence. 15 People in any of these mutual help groups have greater success in achieving abstinence if they become actively involved with their group, as measured by, for example, meeting attendance, having a sponsor or close friend in the group, or volunteering for the group. 15
To help patients engage more deeply in their groups and thus obtain optimal outcomes, clinical interventions have been developed such as the twelve-step facilitation treatment mentioned earlier. A systematic review found that together, clinically-delivered twelve-step facilitation and AA can be as effective as cognitive behavioral or motivational enhancement therapy at reducing drinking intensity, promoting abstinence, and reducing alcohol-related consequences at 12 months. 16 (See Resources for links to therapist manuals to facilitate participation in 12-step and secular mutual help groups.)
Evidence-based specialty treatment for AUD is offered at four basic levels of care or intensity. These levels, as defined by the American Society of Addiction Medicine, form a continuum of care in which patients step up and down in treatment intensity as needed:
Most AUD treatment is provided in outpatient settings. 17,18 About half of AUD patients will have some symptoms of withdrawal when they stop drinking, 2,19 and a small proportion need intensive inpatient or outpatient “detox” to manage potentially dangerous withdrawal symptoms. 2,20 Detox alone does not constitute treatment, however. Continued care in residential or outpatient settings or both is often needed to sustain abstinence and promote long-term recovery. Across settings, a course of AUD treatment is likely to be measured in months, not days or weeks.
If you are uncertain as to which level of care to recommend for a patient, seek a complete assessment by a specialist. If lower intensity outpatient care is appropriate, you can refer to a traditional program, or consider alternatives such as these, which can help maintain your patient’s privacy and routines:
The Navigator and its portal for healthcare professionals can steer you and your patients to quality treatment at all levels of care, from residential to telehealth services. (See Core article on referral.)
In closing, because of the complexity of AUD (and of individuals), no single treatment approach is universally successful or appealing to all patients. The different treatment approaches—behavioral healthcare, medications, and mutual support groups—share similar goals while addressing the varied neurobiological, psychological, and social aspects of AUD. Thus, these approaches are complementary and can work well together in an individualized, flexible, and comprehensive treatment plan.
Alcohol Use Disorder Medication Guides
Mutual Support Groups
Therapy Guides for Mental Health Specialists
Resources to Share with Patients Related to this Article
More resources for a variety of healthcare professionals can be found in the Additional Links for Patient Care.
Read More CloseWe invite healthcare professionals to complete a post-test after reviewing this article to earn FREE continuing education (CME/CE) credit, which is available for physicians, physician assistants, nurses, pharmacists, and psychologists, as well as other healthcare professionals whose licensing boards accept APA or AMA credits. Others may earn a certificate of completion. This CME/CE credit opportunity is jointly provided by the Postgraduate Institute for Medicine and NIAAA.
Correctly Answer 3 of the 4 Post-Test Questions to Earn CME/CE Credit for This Article
Released on 5/6/2022
Expires on 5/10/2025
This activity provides 0.75 CME/CE credits for physicians, physician assistants, nurses, pharmacists, and psychologists, as well as other healthcare professionals whose licensing boards accept APA or AMA credits. Others may earn a certificate of completion. Learn more about credit designations here.
Please note that you will need to log into or create an account on CME University in order to complete this post-test.
After completing this activity, the participant should be better able to:
Contributors to this article for the NIAAA Core Resource on Alcohol include the writers for the full article, content contributors to subsections, reviewers, and editorial staff. These contributors included both experts external to NIAAA as well as NIAAA staff.
Raye Z. Litten, PhD
Editor and Content Advisor for the Core Resource on Alcohol,
Director, Division of Treatment and Recovery, NIAAA
Laura E. Kwako, PhD
Editor and Content Advisor for the Core Resource on Alcohol,
Health Scientist Administrator,
Division of Treatment and Recovery, NIAAA
Maureen B. Gardner
Project Manager, Co-Lead Technical Editor, and
Writer for the Core Resource on Alcohol,
Division of Treatment and Recovery, NIAAA
Sudie Back, PhD
Professor, Department of Psychiatry and
Behavioral Sciences, MUSC
Staff Psychologist, Ralph H. Johnson VA
Medical Center, Charleston, SC
Douglas Berger MD, MLitt
Staff Physician, VA Puget Sound,
Associate Professor of Medicine,
University of Washington, Seattle, WA
Randall Brown MD, PhD
Professor, School of Medicine
& Public Health,
University of Wisconsin, Madison, WI
H. Westley Clark, MD, JD, MPH
Dean's Executive Professor of Public Health,
Santa Clara University, Santa Clara, CA
Barbara J. Mason, PhD
Pearson Family Professor,
The Scripps Research Institute, CA
George F. Koob, PhD
Director, NIAAA
Patricia Powell, PhD
Deputy Director, NIAAA
Nancy Diazgranados, MD, MS, DFAPA
Deputy Clinical Director, NIAAA
Falk W. Lohoff, MD
Lasker Clinical Research Scholar;
Chief, Section on Clinical Genomics and Experimental Therapeutics, NIAAA
Lorenzo Leggio, MD, PhD
NIDA/NIAAA Senior Clinical Investigator and Section Chief;
NIDA Branch Chief;
NIDA Deputy Scientific Director;
Senior Medical Advisor to the NIAAA Director
Aaron White, PhD
Senior Scientific Advisor to
the NIAAA Director, NIAAA
Raye Z. Litten, PhD
Editor and Content Advisor for the Core Resource on Alcohol,
Director, Division of Treatment and Recovery, NIAAA
Laura E. Kwako, PhD
Editor and Content Advisor for the Core Resource on Alcohol,
Health Scientist Administrator,
Division of Treatment and Recovery, NIAAA
Maureen B. Gardner
Project Manager, Co-Lead Technical Editor, and
Writer for the Core Resource on Alcohol,
Division of Treatment and Recovery, NIAAA
Elyssa Warner, PhD
Co-Lead Technical Editor,
Ripple Effect
Daria Turner, MPH
Reference and Resource Analyst,
Ripple Effect
To learn more about CME/CE credit offered as well as disclosures, visit our CME/CE General Information page. You may also click here to learn more about contributors.